ArticleRheumatology (Oxford, England)2025
Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providers.
Matthew A Sherman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it